Literature DB >> 23358982

Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation.

Jan van Noesel1, Ward H van der Ven, Theo A M van Os, Peter W A Kunst, Jitske Weegenaar, Roy J A Reinten, Rama K Kancha, Justus Duyster, Carel J M van Noesel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23358982     DOI： 10.1200/JCO.2012.42.1586

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

Review 1.  Germline mutations predisposing to non-small cell lung cancer.

Authors:  Gerald H Clamon; Aaron D Bossler; Taher Abu Hejleh; Muhammad Furqan
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

2.  Mechanistic Insights into R776H Mediated Activation of Epidermal Growth Factor Receptor Kinase.

Authors:  Zheng Ruan; Natarajan Kannan
Journal:  Biochemistry       Date:  2015-07-06       Impact factor: 3.162

3.  Sequencing study on familial lung squamous cancer.

Authors:  Shaomin Li; Lina Wang; Zhenchuan Ma; Yuefeng Ma; Jiangman Zhao; B O Peng; Zhe Qiao
Journal:  Oncol Lett       Date:  2015-08-07       Impact factor: 2.967

4.  Racial diversity of actionable mutations in non-small cell lung cancer.

Authors:  Aliccia Bollig-Fischer; Wei Chen; Shirish M Gadgeel; Angela S Wenzlaff; Michele L Cote; Ann G Schwartz; Gerold Bepler
Journal:  J Thorac Oncol       Date:  2015-02       Impact factor: 15.609

5.  Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations.

Authors:  Thereasa A Rich; Karen L Reckamp; Young Kwang Chae; Robert C Doebele; Wade T Iams; Michael Oh; Victoria M Raymond; Richard B Lanman; Jonathan W Riess; Thomas E Stinchcombe; Vivek Subbiah; David R Trevarthen; Stephen Fairclough; Jennifer Yen; Oliver Gautschi
Journal:  Clin Cancer Res       Date:  2019-07-12       Impact factor: 12.531

6.  Case report: identification of EGFR R776H and FANCE R381H germline mutations in a patient with multiple pulmonary nodules.

Authors:  Zhenzhen Wu; Yanli Wang; Linling Jin; Juan Wei; Li Han; Junyan Su; Shuliang Cao; Siyao Liu; Xiaohong Duan; Xin Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-26       Impact factor: 4.322

7.  Identifying a wide range of actionable variants using capture-based ultra-deep targeted sequencing in treatment-naive patients with primary lung adenocarcinoma.

Authors:  Lingfeng Chen; Minyan Chen; Jie Lin; Xiaoyan Chen; Xunbin Yu; Zhizhong Chen; Long Jin
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

Review 8.  Inherited lung cancer syndromes targeting never smokers.

Authors:  Hiromasa Yamamoto; Yasushi Yatabe; Shinichi Toyooka
Journal:  Transl Lung Cancer Res       Date:  2018-08

9.  Presentation of EGFR mutations in 162 family probands with multiple primary lung cancer.

Authors:  Chunxiang Li; Yalong Wang; Kai Su; Yu Liu; Liyu Wang; Bo Zheng; Na Yan; Dawei Yuan; Yanxiang Zhang; Liyan Xue; Shugeng Gao; Jie He
Journal:  Transl Lung Cancer Res       Date:  2021-04

10.  Germline mutations and age at onset of lung adenocarcinoma.

Authors:  Karen L Reckamp; Carolyn E Behrendt; Thomas P Slavin; Stacy W Gray; Danielle K Castillo; Marianna Koczywas; Mihaela C Cristea; Kirsten M Babski; Donna Stearns; Catherine A Marcum; Yenni P Rodriguez; Amie J Hass; Mary M Vecchio; Pamela Mora; Aleck E Cervantes; Sharon R Sand; Rosa M Mejia; Terrence C Tsou; Ravi Salgia; Jeffrey N Weitzel
Journal:  Cancer       Date:  2021-04-15       Impact factor: 6.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.